As of 2026-04-05, the Intrinsic Value of Formosa Laboratories Inc (4746.TW) is 71.80 TWD. This 4746.TW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 55.60 TWD, the upside of Formosa Laboratories Inc is 29.10%.
The range of the Intrinsic Value is 50.25 - 114.32 TWD
Based on its market price of 55.60 TWD and our intrinsic valuation, Formosa Laboratories Inc (4746.TW) is undervalued by 29.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 50.25 - 114.32 | 71.80 | 29.1% |
| DCF (Growth 10y) | 67.01 - 144.56 | 93.16 | 67.6% |
| DCF (EBITDA 5y) | 115.57 - 288.11 | 193.81 | 248.6% |
| DCF (EBITDA 10y) | 130.13 - 329.82 | 217.17 | 290.6% |
| Fair Value | 91.79 - 91.79 | 91.79 | 65.10% |
| P/E | 41.39 - 60.29 | 53.75 | -3.3% |
| EV/EBITDA | 2.89 - 116.98 | 53.62 | -3.6% |
| EPV | 30.28 - 52.72 | 41.50 | -25.4% |
| DDM - Stable | 33.08 - 81.13 | 57.11 | 2.7% |
| DDM - Multi | 36.73 - 67.50 | 47.33 | -14.9% |
| Market Cap (mil) | 6,686.46 |
| Beta | 0.76 |
| Outstanding shares (mil) | 120.26 |
| Enterprise Value (mil) | 9,155.22 |
| Market risk premium | 5.98% |
| Cost of Equity | 6.92% |
| Cost of Debt | 5.50% |
| WACC | 5.63% |